Outset Medical(OM)
$4.17-0.05 (-1.18%)
OM
Outset Medical financials statements
$4.17
At close:-0.05 (-1.18%)
Want to see OM full AI Analyst Report?
Outset Medical (OM) Ratios
396 Followers
Outset Medical Ratios
OM's free cash flow for Q3 2026 was $-10.49M. For the 2026 fiscal year, OM's free cash flow was decreased by $-109.00K and operating cash flow was $-10.38M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.67 | 5.69 | 5.26 | 7.19 | 7.93 |
| Quick Ratio | 5.40 | 4.38 | 4.37 | 6.20 | 7.17 |
| Cash Ratio | 0.93 | 2.73 | 1.24 | 1.41 | 3.53 |
| Solvency Ratio | -0.56 | -0.49 | -0.87 | -1.02 | -1.41 |
| Operating Cash Flow Ratio | -1.23 | -2.56 | -2.37 | -2.81 | -2.52 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -64.65 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 113.34M | $ 9.24M | $ 100.30M | $ 219.52M | $ 320.42M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.38 | 0.73 | 0.43 | 0.26 | 0.08 |
| Debt-to-Equity Ratio | 0.80 | 7.53 | 1.11 | 0.42 | 0.10 |
| Debt-to-Capital Ratio | 0.44 | 0.88 | 0.53 | 0.30 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.43 | 0.88 | 0.51 | 0.28 | 0.07 |
| Financial Leverage Ratio | 2.08 | 10.28 | 2.55 | 1.63 | 1.24 |
| Debt Service Coverage Ratio | -4.52 | -3.83 | -12.17 | -42.94 | -72.92 |
| Interest Coverage Ratio | -4.78 | -4.75 | -13.39 | -45.15 | -76.10 |
| Debt to Market Cap | 1.71 | 3.45 | 0.49 | 0.08 | 0.01 |
| Interest Debt Per Share | 7.57 | 65.18 | 45.03 | 33.26 | 13.00 |
| Net Debt to EBITDA | -1.06 | -0.80 | -0.44 | -0.20 | 1.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.13% | 33.92% | 22.24% | 15.46% | 7.42% |
| EBIT Margin | -55.84% | -94.84% | -122.41% | -137.89% | -126.72% |
| EBITDA Margin | -52.21% | -86.10% | -117.96% | -132.45% | -121.69% |
| Operating Profit Margin | -55.84% | -99.72% | -130.22% | -139.56% | -127.21% |
| Pretax Profit Margin | -67.74% | -112.13% | -132.14% | -140.98% | -128.40% |
| Net Profit Margin | -68.34% | -112.57% | -132.54% | -141.24% | -128.59% |
| Continuous Operations Profit Margin | -68.34% | -112.57% | -132.54% | -141.24% | -128.59% |
| Net Income Per EBT | 100.89% | 100.39% | 100.30% | 100.18% | 100.15% |
| EBT Per EBIT | 121.32% | 112.45% | 101.47% | 101.02% | 100.93% |
| Return on Assets (ROA) | -30.87% | -46.40% | -55.07% | -40.73% | -28.47% |
| Return on Equity (ROE) | -64.32% | -477.18% | -140.62% | -66.24% | -35.27% |
| Return on Capital Employed (ROCE) | -29.41% | -49.20% | -65.68% | -46.25% | -31.70% |
| Return on Invested Capital (ROIC) | -29.18% | -48.45% | -65.28% | -46.07% | -31.61% |
| Return on Tangible Assets | -30.87% | -46.40% | -55.07% | -40.73% | -28.47% |
| Earnings Yield | -144.69% | -221.93% | -64.41% | -13.10% | -6.28% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.22 | 3.19 | 3.95 | 4.11 | 4.01 |
| Payables Turnover | 131.27 | 19.45 | 17.40 | 161.76 | 53.88 |
| Inventory Turnover | 1.53 | 1.27 | 2.06 | 1.89 | 2.42 |
| Fixed Asset Turnover | 12.62 | 9.42 | 6.99 | 5.25 | 5.08 |
| Asset Turnover | 0.45 | 0.41 | 0.42 | 0.29 | 0.22 |
| Working Capital Turnover Ratio | 0.56 | 0.51 | 0.47 | 0.34 | 0.31 |
| Cash Conversion Cycle | 322.72 | 384.13 | 248.55 | 279.17 | 234.86 |
| Days of Sales Outstanding | 86.55 | 114.36 | 92.33 | 88.80 | 91.07 |
| Days of Inventory Outstanding | 238.95 | 288.54 | 177.20 | 192.62 | 150.56 |
| Days of Payables Outstanding | 2.78 | 18.76 | 20.98 | 2.26 | 6.77 |
| Operating Cycle | 325.50 | 402.89 | 269.53 | 281.42 | 241.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.05 | -33.58 | -39.74 | -45.39 | -42.86 |
| Free Cash Flow Per Share | -3.10 | -33.84 | -40.78 | -47.98 | -43.88 |
| Dividend Paid and CapEx Coverage Ratio | -58.05 | -127.53 | -38.19 | -17.50 | -41.91 |
| Capital Expenditure Coverage Ratio | -58.05 | -127.53 | -38.19 | -17.50 | -41.91 |
| Operating Cash Flow Coverage Ratio | -0.46 | -0.58 | -0.96 | -1.41 | -3.45 |
| Operating Cash Flow to Sales Ratio | -0.39 | -1.02 | -1.01 | -1.26 | -1.27 |
| Free Cash Flow Yield | -83.51% | -203.27% | -50.25% | -12.39% | -6.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.69 | -0.45 | -1.55 | -7.63 | -15.93 |
| Price-to-Sales (P/S) Ratio | 0.47 | 0.51 | 2.06 | 10.78 | 20.48 |
| Price-to-Book (P/B) Ratio | 0.44 | 2.15 | 2.18 | 5.06 | 5.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.20 | -0.49 | -1.99 | -8.07 | -15.75 |
| Price-to-Operating Cash Flow Ratio | -1.22 | -0.50 | -2.04 | -8.53 | -16.13 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.02 | -0.52 | -0.45 | -7.51 |
| Enterprise Value Multiple | -1.97 | -1.38 | -2.18 | -8.33 | -15.67 |
| Enterprise Value | 122.67M | 135.51M | 335.95M | 1.27B | 1.96B |
| EV to EBITDA | -1.97 | -1.38 | -2.18 | -8.33 | -15.67 |
| EV to Sales | 1.03 | 1.19 | 2.58 | 11.04 | 19.07 |
| EV to Free Cash Flow | -2.60 | -1.16 | -2.49 | -8.27 | -14.67 |
| EV to Operating Cash Flow | -2.65 | -1.17 | -2.56 | -8.74 | -15.02 |
| Tangible Book Value Per Share | 8.35 | 7.74 | 37.17 | 76.61 | 123.08 |
| Shareholders’ Equity Per Share | 8.35 | 7.74 | 37.17 | 76.61 | 123.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 7.85 | 32.83 | 39.44 | 35.93 | 33.76 |
| Net Income Per Share | -5.37 | -36.95 | -52.27 | -50.75 | -43.41 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.21 | 1.18 | 1.08 | 1.02 | 1.01 |
| Research & Development to Revenue | 0.18 | 0.34 | 0.44 | 0.42 | 0.36 |
| SG&A to Revenue | 0.77 | 1.00 | 0.35 | 0.35 | 0.35 |
| Stock-Based Compensation to Revenue | 0.13 | 0.26 | 0.30 | 0.24 | 0.17 |
| Income Quality | 0.57 | 0.91 | 0.76 | 0.89 | 0.99 |
Currency in USD
